OKYO Pharma (LON:OKYO) CEO Gary Jacob speaks to Proactive's Andrew Scott following the news it's submitted a patent application for the potential use of its molecule chemerin for the treatment of symptoms associated with COVID-19 and acute respiratory distress syndrome (ARDS).
The project will be spearheaded by Dr. Napoleone Ferrara, a member of OKYO’s scientific advisory board, who invented the blockbuster drug Avastin®.